MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jtcvs.2025.09.035

Медицинская библиотека · The Journal of thoracic and cardiovascular surgery · 2025

Prognostic influence of biological valve size on long-term outcomes of primary surgical aortic valve replacement for aortic stenosis.

Kutsuzawa Rieko, Kainuma Satoshi, Kawamoto Naonori, Suzuki Kota, Kakuta Takashi, Ikuta Ayumi, Tonai Kohei, Hirayama Masaya, Sakurai Hironobu, Kurashima Shinichi, Irie Yuki, Sakamoto Takahiro, Moriuchi Kenji, Amano Masashi, Okada Atsushi, Takagi Kensuke, Amaki Makoto, Kanzaki Hideaki, Kitai Takeshi, Izumi Chisato, Yamamoto Kazuhiro, Daimon Takashi, Fukushima Satsuki

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

We clarified associations between biological valve sizes selected during primary surgical aortic valve replacement (SAVR) and its long-term outcomes.

METHODS

In total, 754 consecutive patients with aortic stenosis who underwent primary biological SAVR were classified into 3 groups based on valve size: 19-mm (n = 246), 21-mm (n = 262), and ≥23-mm (n = 246). Severe prosthesis-patient mismatch was defined as measured indexed effective orifice area ≤0.65 cm2/m2 if body mass index is < 30 kg/m2 and ≤ 0.55 cm2/m2 if body mass index is ≥ 30 kg/m2. The mean observation period was 6.6 ± 4.0 years (4996 patient-years).

RESULTS

Patients with 19-mm valves were older (19-mm: 74 ± 7.8 years vs 21-mm: 72 ± 8.0 years vs ≥ 23-mm: 69 ± 10 years), predominantly women (91% vs 55% vs 13%), and had smaller body surface area (1.39 ± 0.12 m2 vs 1.53 ± 0.15 m2 vs 1.67 ± 0.16 m2). The incidence of post-SAVR severe prosthesis-patient mismatch was 15%, 5.8%, and 5.0%, respectively (P < .001 for all). However, a mixed-effects model demonstrated that left ventricular mass index regressed equivalently (interaction effect = 0.189). During follow-up, 142 (19%) mortalities and 41 (5.4%) aortic valve reinterventions (31 redo-SAVR and 10 valve-in-valve) were observed, without difference in 10-year all-cause mortality rate (21% vs 33% vs 27%; P = .438). Fine-Gray regression model identified age at surgery (adjusted hazard ratio, 0.4 per 10-years; P < .001) and use of a 19-mm valve (adjusted hazard ratio, 4.0; P < .001) as independent associates with aortic valve reinterventions.

CONCLUSIONS

Despite a higher incidence of severe prosthesis-patient mismatch and aortic reintervention after primary SAVR, use of a 19-mm biological valve can be justified for elderly patients with small body surface area, as evidenced by equivalent long-term survival and left ventricular mass regression to those with larger valves.

Для цитирования: Kutsuzawa Rieko, Kainuma Satoshi, Kawamoto Naonori, Suzuki Kota, Kakuta Takashi, Ikuta Ayumi, Tonai Kohei, Hirayama Masaya, Sakurai Hironobu, Kurashima Shinichi, Irie Yuki, Sakamoto Takahiro, Moriuchi Kenji, Amano Masashi, Okada Atsushi, Takagi Kensuke, Amaki Makoto, Kanzaki Hideaki, Kitai Takeshi, Izumi Chisato, Yamamoto Kazuhiro, Daimon Takashi, Fukushima Satsuki. Prognostic influence of biological valve size on long-term outcomes of primary surgical aortic valve replacement for aortic stenosis.. The Journal of thoracic and cardiovascular surgery. 2025. DOI: 10.1016/j.jtcvs.2025.09.035.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.